MAYO CLINIC

FDA approves AstraZeneca’s self-administered nasal flu vaccine FluMist for ages 2-49, citing its safety and effectiveness since 2003. The vaccine aims to increase convenience and accessibility, though it requires a prescription and has potential side effects like fever, nasal issues, and Guillain-Barré Syndrome.

FDA approves FluMist nasal spray as the first self-administered influenza vaccine, available with prescription for ages 18+ via third-party online pharmacy. Side effects include fever, runny nose, nasal congestion, and sore throat.

Recent cancer research breakthroughs include Oncolytics Biotech's BRACELET-1 study showing promising results for pelareorep in HR+/HER2- breast cancer, Novartis AG's FDA approval of Kisqali for early-stage breast cancer, Lantheus Holdings' positive Phase 3 SPLASH trial results for 177Lu-PNT2002 in prostate cancer, Sutro Biopharma's encouraging Phase 1b study data for Luvelta in ovarian cancer, and Zymeworks' upcoming presentation of preclinical data on its antibody-drug conjugate programs.

Structure Sensor 3, a next-gen 3D scanning platform, offers triple performance, battery life, and durability. Launched post-spinout from Occipital Inc., it aims to enhance healthcare via personalized 3D applications. With an all-new neural processor and advanced SDK, it supports over 300 published applications, empowering developers to innovate in medical devices.

At the 2024 SOHO Annual Meeting, Stephen M. Ansell discussed the shift in Hodgkin lymphoma treatment towards personalized strategies, replacing ABVD and escalated BEACOPP with nivolumab-AVD and BrECADD due to better efficacy and tolerability. The focus is on managing patients based on risk profiles, integrating immunotherapy, and personalizing treatment based on patient frailty and needs.

FDA approves sleep apnea detection for Apple Watch Series 9, 10, and Ultra 2, to be released with watchOS 11. The feature, announced at the iPhone 16 event, requires 10 nights of sleep data over 30 days and is not a diagnostic tool but prompts users to consult healthcare providers. This is not Apple's first foray into sleep apnea detection, following competitors like Withings and Samsung.

Apple's latest updates to Apple Watch and AirPods Pro 2 include sleep apnea detection and hearing aid capabilities, approved by the FDA.

James M. Foran, MD, discusses blastic plasmacytoid dendritic cell neoplasm (BPDCN), emphasizing the importance of recognizing skin lesions and identifying CD123, CD4, and CD56 markers. Foran highlights the challenges in diagnosis and the benefits of a multidisciplinary approach, including the use of tagraxofusp and allogeneic transplantation for long-term remission.

Endomimetics awarded $2.8M SBIR grant to research Bionanomatrix™ coating for flow diverters in treating brain aneurysms, aiming to accelerate endothelialization and reduce thromboembolic risks.

Endomimetics awarded $2.8M SBIR grant to research Bionanomatrix™ coating on flow diverters for brain aneurysm treatment, aiming to accelerate healing and reduce complications.